Metabolism of Propranolol during Percutaneous Absorption in Human Skin

This publication has 8 references indexed in Scilit:

• Extent of cutaneous metabolism during percutaneous absorption of xenobiotics
  Toxicology and Applied Pharmacology, 1989
• Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities
  Clinical Pharmacology & Therapeutics, 1989
• FDA and AAPS Report of the Workshop on Principles and Practices of In Vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalence
  Pharmaceutical Research, 1987
• An in vitro approach to studying cutaneous metabolism and disposition of topically applied xenobiotics
  Toxicology and Applied Pharmacology, 1984
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976
• Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs
  Clinical Pharmacokinetics, 1976
• The pharmacodynamics and metabolism of propranolol in man
  European Journal of Clinical Pharmacology, 1970
• Metabolism of Propranolol (‘Inderal’), a Potent, Specific β-Adrenergic Receptor Blocking Agent
  Nature, 1967